EB病毒，一种抑制性受体激酶，与淋巴瘤
EBV, an inhibited receptor kinase, and lymphoma.
作者信息
Ambinder Richard F
机构信息
JOHNS HOPKINS SCHOOL OF MEDICINE.
出版信息
Blood. 2016 Sep 22;128(12):1542-3. doi: 10.1182/blood-2016-08-724955.
Abstract
In this issue of , Huang et al investigate cellular gene expression profiles in Epstein-Barr virus (EBV)–immortalized B and normal B cells. They present evidence that a viral protein inhibits a cellular receptor tyrosine kinase (RTK) and that this inhibition is important in lymphomagenesis.
摘要
在本期杂志中，黄等人研究了爱泼斯坦-巴尔病毒（EBV）永生化B细胞和正常B细胞中的细胞基因表达谱。他们提供的证据表明，一种病毒蛋白会抑制一种细胞受体酪氨酸激酶（RTK），且这种抑制作用在淋巴瘤发生过程中具有重要意义。
相似文献
1
EBV, an inhibited receptor kinase, and lymphoma.EB病毒，一种抑制性受体激酶，与淋巴瘤
Blood. 2016 Sep 22;128(12):1542-3. doi: 10.1182/blood-2016-08-724955.
2
The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.EB 病毒血清学综合特征与地方性 Burkitt 淋巴瘤的关联。
Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):57-62. doi: 10.1158/1055-9965.EPI-19-0551. Epub 2019 Oct 16.
3
Role of EBV in microRNA dysregulation in Burkitt lymphoma.EBV 在伯基特淋巴瘤中 microRNA 失调中的作用。
Semin Cancer Biol. 2009 Dec;19(6):401-6. doi: 10.1016/j.semcancer.2009.07.003. Epub 2009 Jul 18.
4
[Signification of Epstein-Barr virus detection in the cerebrospinal fluid of a patient with human immunodeficiency virus related Burkitt lymphoma].[爱泼斯坦-巴尔病毒检测在人类免疫缺陷病毒相关伯基特淋巴瘤患者脑脊液中的意义]
Ann Biol Clin (Paris). 2013 May-Jun;71(3):341-4. doi: 10.1684/abc.2013.0814.
5
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.病毒编码的微小RNA有助于EBV阳性伯基特淋巴瘤的分子特征形成。
Oncotarget. 2016 Jan 5;7(1):224-40. doi: 10.18632/oncotarget.4399.
6
Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells.mTOR和钙调神经磷酸酶抑制剂联合疗法对爱泼斯坦-巴尔病毒阳性和阴性伯基特淋巴瘤细胞的影响。
Int Immunopharmacol. 2016 Jan;30:9-17. doi: 10.1016/j.intimp.2015.11.020. Epub 2015 Nov 21.
7
Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.在抗逆转录病毒治疗初治的 HIV-1 感染者中，白细胞介素-2 治疗期间血液中的淋巴瘤和 Epstein-Barr 病毒 DNA：ANRS 119 试验的一个亚研究。
HIV Med. 2014 Jan;15(1):23-9. doi: 10.1111/hiv.12077. Epub 2013 Sep 6.
8
Burkitt lymphoma--a stalking horse for cancer research?伯基特淋巴瘤——癌症研究的幌子？
Semin Cancer Biol. 2009 Dec;19(6):347-50. doi: 10.1016/j.semcancer.2009.07.001. Epub 2009 Jul 14.
9
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.缩肽在爱泼斯坦-巴尔病毒阳性淋巴增殖性疾病异种移植模型中的选择性疗效。
J Natl Cancer Inst. 2004 Oct 6;96(19):1447-57. doi: 10.1093/jnci/djh271.
10
EBV and Burkitt's lymphoma.爱泼斯坦-巴尔病毒与伯基特淋巴瘤
N Engl J Med. 2004 Jun 17;350(25):2621; author reply 2621. doi: 10.1056/NEJM200406173502518.
引用本文的文献
1
Long non-coding RNAs in Epstein-Barr virus-related cancer.爱泼斯坦-巴尔病毒相关癌症中的长链非编码RNA
Cancer Cell Int. 2021 May 25;21(1):278. doi: 10.1186/s12935-021-01986-w.
本文引用的文献
1
EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasation.EphrinA4在人慢性淋巴细胞白血病（CLL）细胞渗出过程中α4和αL介导的细胞存活中起关键作用。
Oncotarget. 2016 Jul 26;7(30):48481-48500. doi: 10.18632/oncotarget.10311.
2
Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival.调控 EBV LMP1 触发的 EphA4 下调在 EBV 相关 B 淋巴瘤中的作用及其对患者生存的影响。
Blood. 2016 Sep 22;128(12):1578-89. doi: 10.1182/blood-2016-02-702530. Epub 2016 Jun 23.
3
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类（2016年修订版）》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
4
EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal.EphA4缺失的微环境通过降低IGF1信号来调节同基因移植的4T1小鼠乳腺癌的癌症发展和类白血病反应。
Cancer Med. 2016 Jun;5(6):1214-27. doi: 10.1002/cam4.670. Epub 2016 Feb 29.
5
The expanding spectrum of EBV+ lymphomas.EBV+ 淋巴瘤的不断扩大的谱系。
Blood. 2015 Aug 13;126(7):827-8. doi: 10.1182/blood-2015-06-648097.
6
EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment.年轻患者的EBV阳性大B细胞淋巴瘤：一种具有耐受性免疫环境证据的淋巴结淋巴瘤。
Blood. 2015 Aug 13;126(7):863-72. doi: 10.1182/blood-2015-02-630632. Epub 2015 May 21.
7
Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.病毒抗原、细胞通路与肿瘤微环境在 EBV 驱动型淋巴瘤发病机制中的相互作用。
Semin Cancer Biol. 2013 Dec;23(6):441-56. doi: 10.1016/j.semcancer.2013.07.005. Epub 2013 Aug 3.
8
Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.全球评估肺腺癌中的 Eph 受体和 Ephrins，鉴定 EphA4 为细胞迁移和侵袭的抑制剂。
Mol Cancer Ther. 2012 Sep;11(9):2021-32. doi: 10.1158/1535-7163.MCT-12-0030. Epub 2012 Jul 17.
9
The curious case of the tumour virus: 50 years of Burkitt's lymphoma.肿瘤病毒的奇闻：伯基特淋巴瘤50年
Nat Rev Microbiol. 2008 Dec;6(12):913-24. doi: 10.1038/nrmicro2015.
Zotero 插件